NNK

ID: Reference9918

C₁₀H₁₃N₃O₂

4-[Methyl(nitroso)amino]-1-(3-pyridinyl)-1-butanone; NNK; 1-Butanone, 4-(methylnitrosamino)-1-(3-pyridyl)-; 1-Butanone, 4-(methylnitrosoamino)-1-(3-pyridinyl)-; 1-Butanone, 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl); 3-(N-Methyl-N-nitrosamino)propyl 3-pyridyl ketone; 4-(Methyl-nitrosamino)-1-(3-pyridyl)-1-butanone

Protectin D1

ID: Reference9921

C₂₂H₃₂O₄

(4Z,7Z,10R,11E,13E,15Z,17S,19Z)-10,17-Dihydroxy-4,7,11,13,15,19-docosahexaenoic acid; (N)PD1; Neuroprotectin D1; PD1; (4Z,7Z,10R,11E,13E,15Z,17S,19Z)-10,17-Dihydroxydocosa-4,7,11,13,15,19-hexaenoic acid; (4Z,7Z,10R,11E,13E,15Z,17S,19Z)-10,17-Dihydroxydocosahexaenoic acid; 10R,17S-Dihydroxy-docosa-4Z,7Z,11E,13E,15Z,19Z-hexaenoate

Leukotriene C4

ID: Reference9924

C₃₀H₄₇N₃O₉S

γ-Glutamyl-S-[(4S,5R,6E,8E,10Z,13Z)-1-carboxy-4-hydroxy-6,8,10,13-nonadecatetraen-5-yl]cysteinylglycine; Leukotriene C₄; Glycine, N-(S-(1-(4-carboxy-1-hydroxybutyl)-2,4,6,9-pentadecatetraenyl)-N-L-γ-glutamyl-L-cysteinyl)-, (R-(R*,S*-(E,E,Z,Z)))-; 5S-hydroxy-6R-(S-glutathionyl)-7E,9E,11Z,14Z-eicosatetraenoic acid

N-(5-{5-[(2S)-1-Cyclobutyl-2-pyrrolidinyl]-1,2,4-oxadiazol-3-yl}-2-pyridinyl)-4-methoxybenzamide

ID: Reference9926

C₂₃H₂₅N₅O₃

N-[5-[5-[(2S)-1-Cyclobutylpyrrolidin-2-yl]-1,2,4-oxadiazol-3-yl]pyridin-2-yl]-4-methoxybenzamide; Benzamide, N-[5-[5-[(2S)-1-cyclobutyl-2-pyrrolidinyl]-1,2,4-oxadiazol-3-yl]-2-pyridinyl]-4-methoxy-; NAT18-437690

N-{4-[(1R,9R)-6-Oxo-11-(phenylsulfonyl)-7,11-diazatricyclo[7.3.1.0^2,7]trideca-2,4-dien-5-yl]phenyl}acetamide

ID: Reference9929

C₂₅H₂₅N₃O₄S

N-[4-[(1R,9R)-11-(Benzenesulfonyl)-6-oxo-7,11-diazatricyclo[7.3.1.02,7]trideca-2,4-dien-5-yl]phenyl]acetamide; Acetamide, N-[4-[(1R,5R)-1,3,4,5,6,8-hexahydro-8-oxo-3-(phenylsulfonyl)-1,5-methano-2H-pyrido[1,2-a][1,5]diazocin-9-yl]phenyl]-; NAT11-285762

N-[4-({[(2R,4S,5R)-5-{6-[4-(Dimethylamino)phenyl]-2-methyl-4-pyrimidinyl}-1-azabicyclo[2.2.2]oct-2-yl]methyl}sulfamoyl)phenyl]acetamide

ID: Reference9930

C₂₉H₃₆N₆O₃S

N-[4-[[(2R,4S,5R)-5-[6-[4-(Dimethylamino)phenyl]-2-methylpyrimidin-4-yl]-1-azabicyclo[2.2.2]octan-2-yl]methylsulfamoyl]phenyl]acetamide; Acetamide, N-[4-[[[[(2R,4S,5R)-5-[6-[4-(dimethylamino)phenyl]-2-methyl-4-pyrimidinyl]-1-azabicyclo[2.2.2]oct-2-yl]methyl]amino]sulfonyl]phenyl]-; NAT13-343191

(1R,9S)-11-(4-Fluorobenzyl)-5-[4-(trifluoromethoxy)phenyl]-7,11-diazatricyclo[7.3.1.0^2,7]trideca-2,4-dien-6-one

ID: Reference9932

C₂₅H₂₂F₄N₂O₂

(1R,9S)-11-[(4-Fluorophenyl)methyl]-5-[4-(trifluoromethoxy)phenyl]-7,11-diazatricyclo[7.3.1.02,7]trideca-2,4-dien-6-one; 1,5-Methano-8H-pyrido[1,2-a][1,5]diazocin-8-one, 3-[(4-fluorophenyl)methyl]-1,2,3,4,5,6-hexahydro-9-[4-(trifluoromethoxy)phenyl]-, (1R,5S)-; NAT11-286840

Solvent orange 2

ID: Reference9934

C₁₇H₁₄N₂O

1-[(E)-(2-Methylphenyl)diazenyl]-2-naphthol; A F Orange No 2; Aizen food orange No 2; Atul oil orange T; C I Solvent orange 2; D & C Orange No 2; Dolkwal orange SS

Flucloxacillin

ID: Reference9936

C₁₉H₁₇ClFN₃O₅S

(2S,5R,6R)-6-({[3-(2-Chloro-6-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; Floxacillin; Floxapen; Flucloxacilina; Flucloxacilline; Flucloxacillinum; (2S,5R,6R)-6-({[3-(2-Chloro-6-fluorophenyl)-5-methylisoxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid

(1R,9R)-N-(4-Fluorophenyl)-5-{[(3-fluorophenyl)sulfonyl]amino}-6-oxo-7,11-diazatricyclo[7.3.1.0^2,7]trideca-2,4-diene-11-carboxamide

ID: Reference9937

C₂₄H₂₂F₂N₄O₄S

(1R,9R)-N-(4-Fluorophenyl)-5-[(3-fluorophenyl)sulfonylamino]-6-oxo-7,11-diazatricyclo[7.3.1.02,7]trideca-2,4-diene-11-carboxamide; 1,5-Methano-2H-pyrido[1,2-a][1,5]diazocine-3(4H)-carboxamide, N-(4-fluorophenyl)-9-[[(3-fluorophenyl)sulfonyl]amino]-1,5,6,8-tetrahydro-8-oxo-, (1R,5R)-; NAT11-308997

3-[(1R,9S)-11-(1-Benzofuran-2-ylmethyl)-6-oxo-7,11-diazatricyclo[7.3.1.0^2,7]trideca-2,4-dien-5-yl]benzonitrile

ID: Reference9938

C₂₇H₂₃N₃O₂

3-[(1R,9S)-11-(1-Benzofuran-2-ylmethyl)-6-oxo-7,11-diazatricyclo[7.3.1.02,7]trideca-2,4-dien-5-yl]benzonitrile; Benzonitrile, 3-[(1R,5S)-3-(2-benzofuranylmethyl)-1,3,4,5,6,8-hexahydro-8-oxo-1,5-methano-2H-pyrido[1,2-a][1,5]diazocin-9-yl]-; NAT11-287205

(3R,4R)-3-{[4-(Benzyloxy)benzoyl]amino}-4-hydroxy-N-[3-(trifluoromethyl)phenyl]-1-azepanecarboxamide

ID: Reference9940

C₂₈H₂₈F₃N₃O₄

(3R,4R)-4-Hydroxy-3-[(4-phenylmethoxybenzoyl)amino]-N-[3-(trifluoromethyl)phenyl]azepane-1-carboxamide; 1H-Azepine-1-carboxamide, hexahydro-4-hydroxy-3-[[4-(phenylmethoxy)benzoyl]amino]-N-[3-(trifluoromethyl)phenyl]-, (3R,4R)-; NAT10-367732